[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Akro

Novo Nordisk has completed its acquisition of Akero Therapeutics for $XXX billion, including a $X CVR tied to future milestones. This deal is expected to significantly impact the global obesity and metabolic disease landscape.

About Akro

AKRO is a biotechnology company focused on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH).

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXXX
X Week: XXXXXXXXX +21,692%
X Month: XXXXXX -XX%
X Months: XXXXXXXXXX -XX%
X Year: XXXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2025-01-12
1-Year Low: X on 2025-10-31

Engagements by network (24h): Reddit: XXX TikTok: XXXXX X: XXXXX YouTube: XXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -X%
X Month: XXX +241%
X Months: XXXXX -XX%
X Year: XXXXXX -XX%
1-Year High: XXXXX on 2024-12-24
1-Year Low: X on 2025-10-31

Mentions by network (24h): Reddit: XX TikTok: XXX X: XX YouTube: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Akro in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XXX
X Week: XXX -XX%
X Month: XXX +67%
X Months: XXXXX -XX%
X Year: XXXXX +22%
1-Year High: XXX on 2024-12-18
1-Year Low: X on 2025-10-31

The most influential creators that mention Akro in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@katarzyna	X	XXX	X	XXX
@maxaelliacro	X	XXXXXX	X	XXX
@iwannabelike	X	XXXXX	X	XXX
@theperfumeguy	X	XXXXXXX	X	XXX
@parfumexquis	X	XXXXXXX	X	XX
@sniffwithsteph9399	X	XXXXXX	X	XX
@glafirkazefirkaa	X	XXXXX	X	XX
@dagunia12	X	XXXXX	X	XX
@redolessence	X	XXXXXXX	X	XX
@persolaise	XX	XXXXXX	X	XX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -X%
1-Year High: XXX% on 2025-10-27
1-Year Low: XX% on 2025-03-30

Most Supportive Themes:

MASH Treatment Focus: (55%) Akero Therapeutics is developing treatments for metabolic dysfunction-associated steatohepatitis (MASH).
High Social Media Engagement: (35%) AKRO is experiencing frequent mentions across various social media platforms, with particularly high engagement observed on TikTok and X.

Most Critical Themes: